Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$2.0BMiss by $10.4MDiluted EPS$1.90Beat by $0.03
Revenue estimate$2.0B
EPS estimate$1.87

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$2.1B
EPS estimate$2.01

Financials

Q3 2025

Income statement

See full
Revenue$2.0B+9.7%
Gross profit$1.4B+12.2%
Operating income$351.3M+25.7%
Net income$230.9M-7.3%
EPS (diluted)$1.16-5.7%

Balance sheet

See full
Cash & equivalents$1.3B+127%
Total debt$8.1B+25.8%
Total equity$12.8B+3.1%
Total assets$23.5B+8.1%

Cash flow

See full
Operating cash flow$418.7M+5.8%
CapEx$55.0M+23.6%
Free cash flow$363.7M+3.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$19.51B-12.1%
Enterprise value$26.33B-6.2%
P/E24.2×+3.7×
P/S2.4×-0.5×

Profitability

See full
Gross margin71.4%-0.3pp
Operating margin16.6%+0.2pp
Net margin10.1%-4.2pp
FCF margin18.5%+0.5pp

Returns & leverage

See full
Return on equity6.4%-2.3pp
Debt / equity0.6×+0.1×
Current ratio2.4×+1.1×

Segments

By product

See full
Knees$792.4M+6.3%
SET$541.5M+19.2%
Hips$506.2M+5.1%
Technology And Data Bone Cement And Surgical$161.3M—

By geography

See full
Americas$1.3B+10.4%
EMEA$417.0M+10.8%
Asia Pacific$330.9M+6.1%

Versus estimates

Revenue

Q1 2026$2.1BBeat by $16.2MQ4 2025$2.2BBeat by $19.9M
Q3 2025$2.0BMiss by $10.4M
Q2 2025$2.1BBeat by $20.5MQ1 2025$1.9BBeat by $13.9MQ4 2024$2.0BBeat by $8.9M

Diluted EPS

Q1 2026$2.09Beat by $0.23Q4 2025$2.42Beat by $0.04
Q3 2025$1.90Beat by $0.03
Q2 2025$2.07Beat by $0.09Q1 2025$1.81Beat by $0.04Q4 2024$2.31Beat by $0.01

Ask the moment Zimmer Biomet Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zimmer Biomet Holdings report Q3 2025 earnings?
Zimmer Biomet Holdings (ZBH) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Zimmer Biomet Holdings's Q3 2025 revenue and EPS?
Zimmer Biomet Holdings reported revenue of $2.0B and diluted EPS of $1.90 for Q3 2025.
Did Zimmer Biomet Holdings beat estimates in Q3 2025?
Revenue missed the consensus estimate of $2.0B by $10.4M. EPS beat the consensus estimate of $1.87 by $0.03.
How did Zimmer Biomet Holdings's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.7% from $1.8B a year earlier and diluted EPS grew 9.2% from $1.74.
Where can I find Zimmer Biomet Holdings's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-265649) and the 10-Q periodic report (0001193125-25-266884) directly on SEC EDGAR. The filing index links above go to sec.gov.